14-104802023-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001137601.3(ZBTB42):c.826C>T(p.Leu276Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,493,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001137601.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZBTB42 | NM_001137601.3 | c.826C>T | p.Leu276Phe | missense_variant | 1/1 | ENST00000342537.8 | |
ZBTB42 | NM_001370342.1 | c.826C>T | p.Leu276Phe | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZBTB42 | ENST00000342537.8 | c.826C>T | p.Leu276Phe | missense_variant | 1/1 | NM_001137601.3 | P1 | ||
ZBTB42 | ENST00000555360.1 | c.826C>T | p.Leu276Phe | missense_variant | 2/2 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000459 AC: 5AN: 108970Hom.: 0 AF XY: 0.0000346 AC XY: 2AN XY: 57776
GnomAD4 exome AF: 0.0000119 AC: 16AN: 1341430Hom.: 0 Cov.: 33 AF XY: 0.00000609 AC XY: 4AN XY: 656552
GnomAD4 genome AF: 0.000138 AC: 21AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.826C>T (p.L276F) alteration is located in exon 2 (coding exon 1) of the ZBTB42 gene. This alteration results from a C to T substitution at nucleotide position 826, causing the leucine (L) at amino acid position 276 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at